Franco-Mateos, E.; Souza-Egipsy, V.; García-Estévez, L.; Pérez-García, J.; Gion, M.; Garrigós, L.; Cortez, P.; Saavedra, C.; Gómez, P.; Ortiz, C.;
et al. Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. Int. J. Mol. Sci. 2024, 25, 3940.
https://doi.org/10.3390/ijms25073940
AMA Style
Franco-Mateos E, Souza-Egipsy V, García-Estévez L, Pérez-García J, Gion M, Garrigós L, Cortez P, Saavedra C, Gómez P, Ortiz C,
et al. Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International Journal of Molecular Sciences. 2024; 25(7):3940.
https://doi.org/10.3390/ijms25073940
Chicago/Turabian Style
Franco-Mateos, Emma, Virginia Souza-Egipsy, Laura García-Estévez, José Pérez-García, María Gion, Laia Garrigós, Patricia Cortez, Cristina Saavedra, Patricia Gómez, Carolina Ortiz,
and et al. 2024. "Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer" International Journal of Molecular Sciences 25, no. 7: 3940.
https://doi.org/10.3390/ijms25073940
APA Style
Franco-Mateos, E., Souza-Egipsy, V., García-Estévez, L., Pérez-García, J., Gion, M., Garrigós, L., Cortez, P., Saavedra, C., Gómez, P., Ortiz, C., Cruz, V. L., Ramos, J., Cortés, J., & Vega, J. F.
(2024). Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimilars for Treating HER2+ Breast Cancer. International Journal of Molecular Sciences, 25(7), 3940.
https://doi.org/10.3390/ijms25073940
